tert-Butyl piperidine-4-carboxylate hydrochloride
CAS : 892493-65-1
Ref. 3D-FT46517
5g | Arrêté | ||
10g | Arrêté | ||
25g | Arrêté | ||
50g | Arrêté | ||
100g | Arrêté |
Informations sur le produit
- 4-Piperidinecarboxylicacid, 1,1-dimethylethyl ester, hydrochloride
- Piperidine-4-carboxylicacid tert-butyl ester hydrochloride
- tert-Butyl piperidine-4-carboxylatehydrochloride
- 4-Piperidinecarboxylic acid tert-butyl ester HCl
- 4-Piperidine carboxylic acid t-butyl ester hydrochloride
- 4-Piperidinecarboxylic acid T-butyl ester HCl
- 4-Piperidinecarboxylicacidt-butylesterHCl
- Isonipecotic acid tert-butyl ester hydrochloride
tert-Butyl piperidine-4-carboxylate hydrochloride is a targeted research chemical with potential applications in the treatment of castration-resistant prostate cancer. It belongs to the class of degraders, which are compounds that selectively degrade specific proteins involved in cancer progression. This compound exhibits favorable pharmacokinetic properties, allowing it to reach metastatic prostate cancer cells and inhibit their growth. tert-Butyl piperidine-4-carboxylate hydrochloride targets androgen receptors, which play a crucial role in the development and progression of castration-resistant prostate cancer. By binding to these receptors and disrupting their function, this compound effectively inhibits tumor growth and metastasis. With its promising potential as a targeted therapy for metastatic castration-resistant prostate cancer, tert-Butyl piperidine-4-carboxylate hydrochloride represents a significant advancement in cancer research.